Omeprol 40 mg/vial (IV Injection)

40 mg vial: ৳ 90.00

Medicine Details

Indications

  • Gastric and duodenal ulcer
  • NSAID-associated duodenal and gastric ulcer
  • Gastro-esophageal reflux disease
  • Acid-related dyspepsia
  • Severe ulcerating reflux esophagitis
  • Prophylaxis of acid aspiration during general anesthesia
  • Zollinger-Ellison syndrome
  • Helicobacter pylori-induced peptic ulcer

Pharmacology

Inhibitor of gastric acid secretion, onset of antisecretory effect within one hour, maximum effect within two hours, inhibition lasts up to 72 hours

Dosage

  • 20 mg once daily for benign gastric and duodenal ulcer
  • 40 mg once daily for prophylaxis of acid aspiration during general anesthesia
  • 20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease
  • 10-20 mg daily for long-term management of acid reflux disease

Administration

IV Injection for prophylaxis of acid aspiration should be given slowly over a period of 5 minutes, IV infusion should be given over a period of 20-30 minutes or more

Interactions

  • Decreased intragastric acidity affecting absorption of ketoconazole
  • Metabolism through cytochrome P450 affecting drugs like diazepam, phenytoin, and warfarin
  • Increased plasma concentrations with clarithromycin during H. pylori eradication
  • No evidence of interaction with alcohol or food

Contraindications

Known hypersensitivity

Side Effects

  • Mild and reversible adverse reactions
  • Skin rash, urticaria, and pruritus reported
  • Diarrhea and headache in some cases
  • Gastrointestinal reactions including constipation, nausea, and flatulence
  • Dizziness, somnolence, insomnia, and vertigo reported
  • Reversible mental confusion, agitation, and depression in severely ill patients

Pregnancy & Lactation

Results from prospective epidemiological studies indicate no adverse effects on pregnancy or fetus/newborn child, breast-feeding discontinuation if use is essential

Precautions & Warnings

  • Avoid concomitant use of clopidogrel
  • Increased risk for osteoporosis-related fractures in observational studies
  • Atrophic gastritis noted occasionally in long-term use
  • Concomitant use with methotrexate may lead to toxicities

Therapeutic Class

Proton Pump Inhibitor

Storage Conditions

Keep in a dry place away from light and heat, keep out of the reach of children

Related Brands